United States · FDA National Drug Code directory

Lansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
46122-744_756f298d-53bd-cd28-216c-4e7d886fdee3
Product NDC
46122-744
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Lansoprazole
Labeler
AMERISOURCEBERGEN DRUG CORPORATION
Marketing category
ANDA
Marketing start / end (source format)
20220412
Source listing expiry
20271231

Source-listed ingredients

  • LANSOPRAZOLE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 3 BOTTLE in 1 CARTON (46122-744-04) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 46122-744-04

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →